University Hospital Limerick

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Prostate cancer2 trials
• Chronic lymphocytic leukaemia1 trial

Phase

• Phase 33 trials

Status

• Active, not recruiting1 trial
• Completed1 trial
• Recruiting1 trial

Lead sponsor

• German CLL Study Group1 trial
• Merck Sharp & Dohme LLC1 trial
• UNICANCER1 trial

Running trials

• Recruiting

  ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)

  NCT04916613· Phase 3· UNICANCER· Source

• Active, not recruiting

  Ibrutinib Monotherapy Versus Fixed-duration Venetoclax Plus Obinutuzumab Versus Fixed-duration Ibrutinib Plus Venetoclax in Patients With Previously Untreated Chronic Lymphocytic Leukaemia (CLL)

  NCT04608318· Phase 3· German CLL Study Group· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Prostate cancer1 recruiting

Closed trials

• Completed

  Phase 3 Study of Pembrolizumab plus Enzalutamide in mCRPC

  NCT03834493· Phase 3· Merck Sharp & Dohme LLC· Source